Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis

Thakore, N. J., Lapin, B. R., Mitsumoto, H., & Pooled Resource Open‐Access ALS Clinical Trials Consortium. (2022). Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis. Muscle & Nerve, 66(6), 702–708. Portico. https://doi.org/10.1002/mus.27724
Authors:
Nimish J Thakore
Brittany R Lapin
Hiroshi Mitsumoto
Pooled Resource Open-Access Als Clinical Trials Consortium
Affiliated Authors:
Hiroshi Mitsumoto
Columbia Affiliation:
Subjects:
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (OpenAlex Topic)
Gene Therapy for Spinal Muscular Atrophy (OpenAlex Topic)
Prion Diseases: Causes and Molecular Basis (OpenAlex Topic)
Amyotrophic Lateral Sclerosis (MeSH)
Neuroprotective Agents (MeSH)
Author Keywords:
survival
prognosis
therapy
diagnostic delay
riluzole
elink
Publication Type:
Article
Unique ID:
10.1002/mus.27724
PMID:
36117390
DOI:
10.1002/mus.27724
Journal:
Muscle and Nerve
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record
View OpenAlex Record

Record Created: